Submission Details
| 510(k) Number | K250501 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 20, 2025 |
| Decision Date | November 14, 2025 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K250501 is an FDA 510(k) clearance for the System Sophi, a Unit, Phacofragmentation (Class II — Special Controls, product code HQC), submitted by This AG (Heerbrugg, CH). The FDA issued a Cleared decision on November 14, 2025, 267 days after receiving the submission on February 20, 2025. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.4670.
| 510(k) Number | K250501 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 20, 2025 |
| Decision Date | November 14, 2025 |
| Days to Decision | 267 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | HQC — Unit, Phacofragmentation |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.4670 |